Consistent with a potential implication of MAP4K4 in sensitization of tumor cells to chemotherapy, MAP4K4 was recently found to reduce the sensitivity of cervical cancer cells to cisplatin treatment via an autophagy-controlled mechanism (59). Here, MAP4K4 is linked to cervical carcinoma.